Watch Demo

The Czech Republic Anti-Infective Industry Outlook 2022 - 2026

See how the Czech Republic Anti-Infective performed compared to key markets such as the United Kingdom, Germany and South Korea.

Key Market Indicators

Sales of Czech antiinfective medicines are expected to reach over $515 million by 2026, up from $458 million in 2021. This is a growth rate of 2.1% year on year on average since 1995, when the market grew 9.2%. In 2021, the Czech Republic ranked 14th in the world, with Switzerland ahead at $458 million. Germany, South Korea, and Italy followed in second, third, and fourth place respectively. Czech imports of antibiotics are due to reach $27.6 million by 2026, up from $24.6 million in 2021. This is a growth rate of 2.1% year on year on average since 1998, when the demand rose 10.7%. Exports of Czech antibiotics are projected to reach $9 million by 2026, down from $13.5 million in 2021. This is a decrease of 6.3% year on year on average since 1998, when the supply was unchanged. In 2021, Czech Republic ranked 26th globally, with Slovakia ahead at $13.5 million. Switzerland, Italy, and India placed second, third, and fourth respectively.

Marketing Banner

The Czech Republic Anti-Infective Market Data and Forecasts

How much will the Czech Republic Anti-Infective Market grow to 2026?

Forecast: Antiinfective Medicine Sales in the Czech Republic
Forecast: Antibacterial Medicine Sales in the Czech Republic
Forecast: Antiinfective Medicine Sales in the Czech Republic
Forecast: Antibacterial Medicine Sales in the Czech Republic
Forecast: Antibacterial Medicine Sales in the Czech Republic
More in Anti-Infective Industry for 2028

Improve your Knowledge with the latest Indicators and Trends